JSLL · Health Care · 2026-08-07

Jeena Sikho Lifecare Ltd

Stage 4 · wk 7In scan: Breakout WatchMARKET: BULL TOPPING · 2026-08-07
₹598.1
-1.02% today
₹7,434 Cr · Mid cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Jeena Sikho Lifecare Limited trades in ayurvedic medicines in India. The company offers ayurvedic products under the Shuddhi brand name. It also provides services, including in-patient, out-patient, 72 hours health camps, Panchakarma therapies, dietary support and nutrition guidance, home-based healthcare services, and healthcare support centre services. In addition, the company operates clinics under the Shuddhi Ayurveda, Shuddhi Clinics, Hospital & Institution of Integrated Medical Sciences, Shuddhi Wellness Clinics & Hospital, Shuddhi Ayurveda Panchakarma Hospital, and Shuddhi Panchakarma Day Care Clinic names. Jeena Sikho Lifecare Limited was founded in 2009 and is headquartered in Zirakpur, India.

Visit company website →
P/E (TTM)
36.7
Forward 19.8
Earnings Growth (YoY)
+404.7%
Revenue +91.6%
Dividend Yield
0.17%
P/B 22.0
vs 52W High
-28.5%
₹492.2 lo₹836.8 hi
28.5% below 52W high — ongoing decline
In Stage 4, distance from the 52W high reflects ongoing decline — not a discount. Avoid catching falling knives.
Stage Maturity
Week 7
1w13w26w
Week 7 — early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure — there's no 'bottom' time to buy.
vs 200 DMA
-9.3%
200 DMA: ₹659.6 · sloping down
In Stage 4, the stock is below its 200 DMA — the hallmark of a downtrend. No long positions warranted until this reverses structurally.
Rel Volume
0.24x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low volume bounces are typical — they lack real buyers and should not be mistaken for reversals.
Trend Health
→
MA20 flat · -0.1% vs MA50 -6.9%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
Sector has 79 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
→ Flat
Stage 2%
50.5%
20d Δ
+0.5pp
1M return
+1.9%
3M return
+11.7%
Industry Stage-2 % · last 20 days
Industry has 53 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-12 → 2026-08-07
S2 35w
S2 52w
S4 15w
2023-05-122026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 35w → S3 5w → S2 52w → S3 10w → S2 7w → S3 1w → S4 12w → S1 12w → S4 15w → S3 1w → S4 8w → S1 5w → S4 6w current
Total tracked: 168 weeks across 13 stage runs.
1M
+1.1%
3M
-20.1%
6M
-7.8%
YTD
-13.9%
1Y
+7.9%
Scan Membership
Breakout Watch
Latest: 2025-04-22
2 appearances in last 60 days. First seen: 2024-02-14.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S4
Wk 7 · Vol —x
2026-08-06S4
Wk 6 · Vol —x
2026-08-05S4
Wk 6 · Vol —x
2026-08-04S4
Wk 6 · Vol —x
2026-08-03S4
Wk 6 · Vol —x
2026-07-31S4
Wk 6 · Vol —x
2026-07-30S4
Wk 5 · Vol —x
2026-07-29S4
Wk 5 · Vol —x
2026-07-28S4
Wk 5 · Vol —x
2026-07-27S4
Wk 5 · Vol —x
2026-07-24S4
Wk 5 · Vol —x
2026-07-23S4
Wk 4 · Vol —x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹584.3
200 DMA
₹659.6
52W High
₹836.8
52W Low
₹492.2
5D Low
₹574.2
Resistance levels (recent highs)
20d High
₹604.3
60d High
₹692.3
120d High
₹773.7
250d High
₹836.8
Next resistance
+1.0%
to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.